NEWSROOM
McDermott Advised Servier in its License Option Agreement with OSE Immunotherapeutics
January 10, 2017
Read time: 2 min
Emmanuelle Trombe, Anthony Paronneau, Raphaëlle Monjou and Louise Aberg advised France’s Servier, an international pharmaceutical company, in its license option agreement with OSE Immunotherapeutics on the exclusive worldwide rights to commercialize a monoclonal immunomodulatory antibody.
Wir empfehlen Ihnen ebenfalls
